Strathspey Crown and the first Medicare-Medicaid opt-out company in medtech | A conversation with Robert Grant
December 3, 2012 by Brian Johnson
In this MassDevice Big 100 West preview, we talk to Strathspey Crown Chairman Robert Grant about how his private equity firm Strathspey Crown is looking to break the mold.
If Robert Grant is successful – a good bet, judging by his track record – 1 day his new venture, private equity firm Strathspey Crown, will be known as a leader in the nascent field of "lifestyle medicine."
Permalink
Features
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
